Sofosbuvir Plus Ribavirin and Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 or 3 Hepatitis C Virus and Severe Renal Impairment: a Multicentre, Phase 2b, Non-Randomised, Open-Label Study
The Lancet Gastroenterology & hepatology(2020)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要